Novartis AG v. Actavis Elizabeth LLC
1:14-cv-01487
📡 5G SEP • ETSI DeclaredOverview
Parties
Defendant
HEC Pharm USA Inc. Operating Company
Represented By
1 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
HEC Pharm Co. Ltd. Operating Company
Represented By
7 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Ezra Ventures LLC NPE (Patent Assertion Entity)
Represented By
3 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Mitsubishi Tanabe Pharma Corporation NPE (University / Research)
Represented By
4 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Actavis Elizabeth LLC Operating Company
Represented By
2 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Actavis Inc. Operating Company
Represented By
5 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Apotex Corp. Operating Company
Represented By
6 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Novartis AG Operating Company
Represented By
13 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis Pharmaceuticals Corporation Operating Company
Represented By
5 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Mitsui Sugar Co. Ltd. NPE (University / Research)
Represented By
4 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Counter Claimant
HEC Pharm Group Operating Company
Represented By
1 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Interested Party
Apotex Inc. Operating Company
Represented By
6 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,604,229 Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US 5,719,176 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 5,952,316 A | US Continuation / Sibling | View Official Patent → |
| 🇯🇵 Japan | JP 28328192 | Japan Counterpart | View Official Patent → |
| 🇯🇵 Japan | JP 17942793 | Japan Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1994008943 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 47,883,495 A | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP • ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5604229
2-amino-1,3-propanediol compound and immunosuppressant
|
Filed: 1993-10-18
Issued: 1997-02-18
|
Expired (Term Ended)
+1949d PTA
Expires: 2019-02-18
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1949 days) / Cellect Scrutiny — Over 1949 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
88
Dispositive
61
Granted
0
Denied
2
Pending / Review
65
Motions by Category
Key Dispositive Motions & Rulings